# Recombinant Factor C Assay Market to Rear Excessive Growth During 2019 – 2027 Author: Pal Sinha, Barnali Author URL: https://financedigest.com/author/pal-sinha-barnali Published: 2021-11-15 Category: Research Reports Category URL: https://financedigest.com/category/research-reports Meta Title: Recombinant Factor C Assay Market: Sustainable Endotoxin Meta Description: Discover how the synthetic equivalent of Factor C is revolutionising endotoxin testing, leading to sustainable solutions in healthcare. URL: https://financedigest.com/recombinant-factor-c-assay-market-to-rear-excessive-growth-during-2019-2027html ![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/research-report-1-14-1736837316358-compressed.jpg) **Recombinant Factor C Assay a Sustainable Endotoxin Testing Solution** Recombinant factor C (rFC) assay is a synthetic equivalent of Factor C and is the first component of the horseshoe crab clotting cascade, which is activated in response to endotoxins. Moreover, the horseshoe crab blood can be collected only during a short time frame, thus limiting its supply considerably. Hence, healthcare companies in the recombinant factor C assay [market are increasing their focus on rFC methods to help alleviate this challenge and improve](https://www.financedigest.com/uk-housing-market-weakness-continues-improvement-on-the-horizon-rics.html "UK housing market weakness continues, improvement on the horizon – RICS") outcomes. **Read Report Overview:** [https://www.transparencymarketresearch.com/recombinant-factor-c-assay-market.html](https://www.transparencymarketresearch.com/recombinant-factor-c-assay-market.html) Novel rFC methods are benefitting healthcare companies, as these [companies can limit their reliance on animals or any other source materials](https://www.financedigest.com/uk-to-fine-tech-companies-that-fail-to-remove-self-harm-material.html "UK to fine tech companies that fail to remove self-harm material"). Hence, recombinant factor C assay is acquiring popularity as a sustainable solution for endotoxin testing. Such advancements have led to the [growth of the recombinant factor C assay market](https://www.financedigest.com/andro-supplements-market-2022-present-scenario-and-growth-prospects-2028.html "Andro Supplements Market 2022 | Present Scenario and Growth Prospects 2028"), where the market is estimated to reach a revenue of ~ **US$ 28 Mn** by the end of **2027**. Analysts of Transparency Market Research (TMR) opine that rFC will gain recognition in the endotoxin testing industry for its accuracy and specificity, which is as good as the LAL (Limulus Amebocyte Lysate) assay. **Request Brochure of Report** **–** [https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep\_id=36044](https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=36044) PyroGene rFC Benefits Pharmaceutical Companies Due to Single-step Enzymatic Process PyroGene™ recombinant [factor C assay is gaining market](https://www.financedigest.com/mould-inhibitors-market-in-depth-overview-growth-factors-regional-analysis-and-forecasts-outlook-2030.html "Mould Inhibitors Market In-Depth Overview, Growth Factors, Regional Analysis And Forecasts Outlook-2030") prominence as a single-step enzymatic process as opposed to LAL assay that involves multiple procedural steps. As such, the PyroGene brand is anticipated to dictate the highest revenue as compared to EndoNext in the recombinant factor C assay [market where the market is predicted to grow at a favorable CAGR](https://www.financedigest.com/magnetic-sensor-market-at-a-cagr-of-5-1-during-2022-28.html "Magnetic Sensor Market at a CAGR of 5.1% during 2022-28") of ~9% during the forecast period. Monitoring samples for contaminants play a pivotal role in pharmaceutical and [medical device industries](https://www.financedigest.com/medical-dynamometer-market-industry-outlook-growth-prospects-and-key-opportunities.html "Medical Dynamometer Market: Industry Outlook, Growth Prospects and Key Opportunities"). This explains why the revenue of pharmaceutical companies is estimated to be the highest among all [end users in the market](https://www.financedigest.com/ball-screw-market-competitive-growth-strategies-based-on-type-applications-end-user-and-region.html "Ball screw Market Competitive Growth Strategies Based on Type, Applications, End User and Region") landscape. Traditional LAL [testing is largely dependent on the blood](https://www.financedigest.com/feasibility-of-interoperability-to-drive-the-blood-testing-market.html "Feasibility of interoperability to drive the Blood Testing Market") of the horseshoe crab namely Limulus polyphemus. However, multiple enzymatic steps associated with LAL assay is majorly dependent on the availability of horseshoe crabs. Hence, [companies in the recombinant factor C assay market are increasing their research spending in PyroGene recombinant factor C assay that can be associated with innovative software systems](https://www.financedigest.com/setsquared-companys-maths-system-adds-up-to-pitch-perfect-palace-success.html "SETsquared company’s maths system adds up to pitch-perfect palace success") to gain a read-incubate-read sequence within the workflow. **Request for Custom Research** **–** [https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep\_id=36044](https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=36044) ## Consolidated Nature of Market to Attract Attention of Healthcare Giants LAL assays are considered as the gold standard for endotoxin testing. However, advantages of recombinant [factor C assay are transforming the market](https://www.financedigest.com/the-transforming-growth-factors-market-to-stand-on-quality-assured-digitization.html "The Transforming Growth Factors Market to stand on quality assured digitization") landscape, which is dictated by only two major companies. Lonza Group— a [leading Swiss multinational biotechnology company](https://www.financedigest.com/infrared-thermometer-market-2021-global-leading-companies-analysis-revenue-trends-and-forecasts-2026.html "Infrared Thermometer Market 2021 Global Leading Companies Analysis, Revenue, Trends and Forecasts 2026") is increasing efforts to make its PyroGeneTM recombinant factor C assay a compendial method in Europe by collaborating with the European Pharmacopoeia. On the other hand, Hyglos GmbH— a bioMérieux company, which is a global player in [in vitro diagnostics](https://www.transparencymarketresearch.com/in-vitro-diagnostic-tests.html), is increasing efforts to reduce the incidence of false positives from ß-Glucan or interference due to colored or turbid samples. Thus, healthcare companies worldwide should tap opportunities in rFC, since the recombinant [factor C assay market](https://www.financedigest.com/influential-factors-determining-the-trajectory-of-the-automatic-barriers-and-bollards-market-2021-2031.html "Influential Factors Determining the Trajectory of the Automatic Barriers and Bollards Market 2021 – 2031") is consolidated. **Buy** **Recombinant Factor C Assay Market Report at** [https://www.transparencymarketresearch.com/checkout.php?rep\_id=36044<ype=S](https://www.transparencymarketresearch.com/checkout.php?rep_id=36044<ype=S) Companies in the recombinant factor C assay [market are reducing the pressure on LAL assays for innovations](https://www.financedigest.com/the-date-syrup-market-to-fathom-the-depth-of-innovation.html "The Date Syrup Market To Fathom The Depth Of Innovation") in monitoring samples for contaminants in pharmaceutical products. However, lack of long-term studies that validate rFC for combination testing of unknown samples, inter-laboratory, -operator, and -lot changes poses a barrier for [market growth](https://www.financedigest.com/automotive-seating-market-challenges-drivers-outlook-growth-opportunities-analysis-to-2026.html "Automotive Seating Market Challenges, Drivers, Outlook, Growth Opportunities – Analysis to 2026"). Hence, pharmaceutical test users are increasing their efficacy in research [studies to validate successful](https://www.financedigest.com/astrazeneca-antibody-cocktail-study-shows-success-treating-covid-19.html "AstraZeneca antibody cocktail study shows success treating COVID-19") outcomes of rFC in specific products. **Effective FDA-approved Drug Builds Credibility of Healthcare Companies** Companies in the recombinant factor C assay [market are gaining competitive edge over other players](https://www.financedigest.com/spa-market-recent-industry-developments-and-growth-strategies-adopted-by-players.html "Spa Market: Recent Industry Developments and Growth Strategies Adopted by Players") by introducing FDA-approved drugs using rFC. They are increasing efforts to experiment with humanized [monoclonal antibodies](https://www.transparencymarketresearch.com/monoclonal-antibody-therapeutics-market.html) such as galcanezumab for the prevention of migraine in adults. Novel rFC methods are being highly publicized as non-animal alternatives for the assessment of contaminating endotoxins in drugs. Though LAL is considered as the gold standard for endotoxin testing, official declarations by the FDA are validating the efficiency of PyroGene in the recombinant factor C assay [market landscape](https://www.financedigest.com/histidine-market-outlook-current-and-future-industry-landscape-analysis-2029.html "Histidine Market Outlook, Current and Future Industry Landscape Analysis 2029"). Thus, accuracy, sensitivity, and specificity of recombinant [factor C assay is being considered](https://www.financedigest.com/7-factors-to-consider-before-your-business-moves-to-a-subscription-model.html "7 Factors to Consider Before Your Business Moves to a Subscription Model") at par with LAL methods. **About Us** Transparency [Market Research is a next-generation market intelligence](https://www.financedigest.com/artificial-intelligence-ai-to-catalyze-the-cell-analysis-instruments-market.html "Artificial Intelligence (AI) to catalyze the Cell Analysis Instruments Market") provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time [data collection methods along with ability to track more than one million high growth](https://www.financedigest.com/bridge-the-gaps-in-big-data-and-cross-into-a-world-of-growth.html "Bridge the gaps in Big Data – and cross into a world of growth") niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts [offer insights](https://www.financedigest.com/meningococcal-vaccines-market-study-offering-deep-insight-related-to-growth-trends-until-2026.html "Meningococcal Vaccines Market Study Offering Deep Insight Related to Growth Trends Until 2026") for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help [enterprises reach](https://www.financedigest.com/demand-for-lifesciences-enterprise-storage-market-to-reach-us-2-6-bn-by-2026.html "Demand for Lifesciences Enterprise Storage Market to Reach US$ 2.6 Bn by 2026") right decision. **Contact** **Mr. Rohit Bhisey** Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY – 12207 United States USA – Canada Toll Free: 866-552-3453 Email: [sales@transparencymarketresearch.com](mailto:sales@transparencymarketresearch.com) Website: [https://www.transparencymarketresearch.com/](https://www.transparencymarketresearch.com/) --- This blog is powered by Superblog. Visit https://superblog.ai to know more. ---